[
1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2022. Available from: http://goldcopd.org. Last accessed: 11 March 2022.
]Search in Google Scholar
[
2. Almagro P, Calbo E, Echaguien A et al. Mortality after hospitalization for COPD. Chest 2002; 121(5):1441-1448.10.1378/chest.121.5.144112006426
]Search in Google Scholar
[
3. Connors A, Dawson N, Thomas C et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to understand prognoses and preferences for outcomes and risks of treatments) American Journal of Respiratory and Critical Care Medicine 1996; 154(4):959-967.10.1164/ajrccm.154.4.8887592
]Search in Google Scholar
[
4. Gudmundsson G, Gislason T, Lindberg E et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respiratory Research 2006; 7(1):109.10.1186/1465-9921-7-109156038116914029
]Search in Google Scholar
[
5. Kim S, Clark S, Camargo C. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD: Journal of COPD 2006; 3(2):75-81.10.1080/1541255060065127117175669
]Search in Google Scholar
[
6. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5):1434-1440.10.1378/chest.121.5.143412006425
]Search in Google Scholar
[
7. Piquet J, Chavaillon J-M, David P, Martin F, Blanchon F, Roche N, French College of General Hospital Respiratory Physicians (CPHG). High-risk patients following hospitalisation for an acute exacerbation of COPD. Europ Respir J 2013; 42:946-955.10.1183/09031936.0018031223349446
]Search in Google Scholar
[
8. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60(11):925-931.10.1136/thx.2005.040527174723516055622
]Search in Google Scholar
[
9. Divo M, Cote C, Torres J et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012;186(2):155-161.10.1164/rccm.201201-0034OC22561964
]Search in Google Scholar
[
10. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. The Am J Med 2006; 119(10):812-819.10.1016/j.amjmed.2006.02.03117000207
]Search in Google Scholar
[
11. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962-969.10.1183/09031936.0001240818579551
]Search in Google Scholar
[
12. Benson R, Kazmi N, Pocock A et al. Impact of diabetes in patients admitted with acute exacerbation of COPD [Abstract 883s]. Eur Respir J 2012; 40(Suppl. 56).
]Search in Google Scholar
[
13. Schelini K, Tanni S, Zamuner A et al. The influence of metabolic syndrome in mortality rate of COPD patients: a five years follow up study [Abstract 81s]. Eur Respir J 2012; 40(Suppl 56).
]Search in Google Scholar
[
14. Holmgaard DB, Mygind LH, Titlestad IL et al. Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality – results from a 10-year prospective cohort study. PLoS ONE 2013; 8:e53670.10.1371/journal.pone.0053670354486223341971
]Search in Google Scholar
[
15. Borissova A-M, Shinkov A, Vlahov J et al. Determination of the optimal level of 25(OH)D in the Bulgarian population. Endocrinologia 2012; 17(3):135-142.
]Search in Google Scholar
[
16. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diab Care 2012; 35:S64-S71.10.2337/dc12-s064363217422187472
]Search in Google Scholar
[
17. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640–1645.10.1161/CIRCULATIONAHA.109.19264419805654
]Search in Google Scholar
[
18. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.10.1183/09031936.05.0003480516055882
]Search in Google Scholar
[
19. Mekov E, Slavova Y, Tsakova et al. Vitamin D deficiency and insufficiency in hospitalized COPD patients. PLoS ONE 2015; 10(6):e0129080.10.1371/journal.pone.0129080445788526047485
]Search in Google Scholar
[
20. Mekov E, Slavova Y, Tsakova A et al. Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease. PeerJ 2015; 3:e1068.10.7717/peerj.1068449369826157632
]Search in Google Scholar
[
21. Mekov E, Slavova Y, Tsakova A et al. One-year mortality after severe COPD exacerbation in Bulgaria. PeerJ 2016; 4:e2788.10.7717/peerj.2788515719227994981
]Search in Google Scholar
